Clinical Trial Update: An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated palbociclib in combination with Velcade (bortezomib) and dexamethasone in patients with multiple myeloma and has completed. Results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Palbociclib (palbociclib)
• Velcade (bortezomib)

Snippet

Sponsor: Pfizer | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2015-03-19